7Baggers
 Bio Green Med Solution Appoints New Independent Director  TipRanks Thu, 25 Sep 2025 10:48:48 GMT
 published on: 2025-09-17 01:25:53  newser.com Wed, 17 Sep 2025 06:25:53 GMT
 cyclacel pharmaceuticals: recent acquisition completed  MSN Wed, 17 Sep 2025 00:44:40 GMT
 Bio Green Med Solution Faces Nasdaq Delisting Notice  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 international business times  FinancialContent Fri, 12 Sep 2025 10:00:00 GMT
 Cyclacel Pharmaceuticals: Recent Acquisition Completed  TipRanks Fri, 12 Sep 2025 07:00:00 GMT
 major shareholder cashes out big on cyclacel pharmaceuticals!  TipRanks Thu, 11 Sep 2025 02:07:37 GMT
 kua khai loon sells cyclacel (cycc) shares worth $133,568 by investing.com  Investing.com South Africa Thu, 11 Sep 2025 00:12:19 GMT
 Kua Khai Loon sells Cyclacel (CYCC) shares worth $133,568  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 major shareholder cashes out big on cyclacel pharmaceuticals!  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 cyclacel pharmaceuticals approves key shareholder proposals  TipRanks Sat, 06 Sep 2025 02:16:38 GMT
 Cyclacel Pharmaceuticals Approves Key Shareholder Proposals  TipRanks Fri, 05 Sep 2025 07:00:00 GMT
 Cyclacel Pharmaceuticals Enters Warrant Exchange Agreement  The Globe and Mail Fri, 05 Sep 2025 07:00:00 GMT
 Cyclacel Pharmaceuticals Enters Warrant Exchange Agreement  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 Cyclacel Pharmaceuticals Amends Stock Purchase Warrants  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 01:23:29  Newser Sun, 31 Aug 2025 02:00:03 GMT
 top chart patterns to watch in cyclacel pharmaceuticals inc.  Newser Mon, 25 Aug 2025 06:48:35 GMT
 cyclacel pharmaceuticals announces amendment to exchange agreement  ADVFN Brasil Sun, 24 Aug 2025 10:16:09 GMT

Cyclacel Pharmaceuticals, Inc
(NASDAQ:CYCC) 

CYCC stock logo

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial f...

Founded: 1996
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends